Project Grant K01DK144668
- Federal Grant Award Summary Vanderbilt University Medical Center received a $175,000 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective May 20, 2026, with a completion date of April 30, 2028. The award funds basic biomedical research focused on spatial profiling of pancreatic N-glycosylation in Type 1 Diabetes (T1D), addressing critical...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Alabama at Birmingham a five-year K01 career development grant of $152,524 (awarded May 15, 2026; completion March 31, 2031) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports Principal Investigator Seung-Yup "Joshua" Lee, PhD, in developing MedBridge (Medication Bridge at Care Transition), an...
- Summary of Federal Project Grant Award The University of Michigan received a $769,155 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), with an award date of September 12, 2025, and completion date of July 31, 2030. The grant funds the Michigan Diabetes Project, a research initiative designed to develop and evaluate a virtually administered,...
- Federal Project Grant Award Summary Vanderbilt University received a $140,644 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), with an award date of December 13, 2025, and completion date of June 30, 2029. The research project, conducted at Vanderbilt's Nashville, Tennessee facility, focuses on identifying mechanisms of T follicular helper (TFH)...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded New York University School of Medicine a $158,943 Project Grant on July 15, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This five-year initiative, scheduled for completion by May 31, 2030, develops and tests a community health worker (CHW)-led intervention designed to support South Asian patients with Type 2 Diabetes who are at...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded $177,877 to the Regents of the University of Minnesota on April 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for a five-year project period concluding March 31, 2031. This K23 career development award funds the development and pilot evaluation of TEAM-T2D (Technology-Enhanced Adherence to Medication Intervention for Youth Type 2...
- Federal Project Grant Award Summary Vanderbilt University's Sponsored Programs Administration received a $172,234 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for the research project titled "CERS2-Dependent Sphingolipid Control of Human Beta-Cell Function and Resilience." The award, effective May 15, 2026, with completion by April 30,...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Washington University in St. Louis $138,753 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on September 15, 2025, with completion scheduled for July 31, 2028. This K01 Mentored Career Development Award supports a researcher's transition to an independent investigator role in diabetes research through an integrated program combining...
- Federal Grant Award Summary Vanderbilt University Medical Center received a $866,265 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective May 13, 2026, through January 31, 2031. The award supports biomedical research investigating non-canonical signaling mechanisms in acute kidney injury (AKI) and its progression to chronic kidney disease (CKD),...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Illinois a $295,494 Project Grant on September 15, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to support the ACCELERATED-T2D research initiative. The project, which extends through August 31, 2030, will investigate the pathways linking socioeconomic status (SES) to glycemic control and diabetes...
Vanderbilt University Medical Center received a $146,248 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective June 1, 2026, with completion targeted for February 28, 2030. This K01 mentored career development award supports the adaptation and development of a technology-delivered diabetes self-management support intervention specifically designed for adults with Type 2 diabetes and cognitive dysfunction. The project represents a novel application of evidence-based rehabilitation techniques to address the complex relationship between diabetes management and cognitive impairment, where disease severity and cognitive decline create reciprocal challenges for disease management. The primary deliverable is a scalable, technology-enabled self-management intervention tailored for patients with cognitive dysfunction and their support persons. Through this award, the principal investigator will complete structured mentored training to develop expertise in clinical diabetes management, mixed-methods intervention adaptation, cognitive screening in primary care settings, and clinical trial leadership. The project aims to fill a critical gap in the literature by creating the first rehabilitation-informed intervention of its kind for this vulnerable population, ultimately contributing evidence-based approaches to support disease management in adults experiencing both diabetes and cognitive dysfunction.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $146.2k | 5/26/26 |